Also, high PD-1/PD-L1 expression was illustrated to be strongly related with radiosensitivity, suggesting that the combination of radiotherapy and anti-PD-1/PD-L1 therapy may improve the prognosis of HNSCC patients [31]. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.